Condyloma Acuminata
6
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
33%
2 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)
Safety and Tolerability Study of V501 in Japanese Boys (V501-200)
Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)
Safety and Efficacy Study to Test Topical AS101 for External Genital Warts
The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients